全球医疗环境中可预防患者伤害的患病率、严重程度与性质:系统综述与荟萃分析
该系统综述与荟萃分析纳入2000年1月至2019年1月间70项观察性研究、共337 025例患者,评估医疗环境中可预防患者伤害的患病率、严重程度与类型。结果显示可预防患者伤害的合并患病率为6%,其中12%为严重或致死性伤害,药物相关事件占25%、其他治疗相关事件占24%,且高级专科(重症监护或手术)高于综合医院。
要点
- 可预防患者伤害的合并患病率约为6%(每20例患者中约1例)。
- 可预防伤害中12%为严重或致死性,药物相关事件占25%、其他治疗相关事件占24%。
- 高级专科(重症监护或手术)的可预防伤害患病率高于综合医院。
核心结论
- 约二十分之一的患者在接受医疗照护时暴露于可预防伤害。
- 可预防患者伤害中约12%为严重或致死性。
- 药物和其他治疗相关事件占可预防患者伤害的最大比例。
- 高级专科(重症监护或手术)的可预防伤害患病率高于综合医院。
- 亟需针对可预防患者伤害而非全部患者伤害制定并实施循证缓解策略。
研究设计与样本
- 系统综述与荟萃分析,检索Medline、PubMed、PsycINFO、Cinahl、Embase、WHOLIS、Google Scholar及SIGLE自2000年1月至2019年1月的文献。
- 纳入报告医疗照护中可预防患者伤害的观察性研究。
- 最终纳入70项研究,涉及337 025例患者。
- 采用随机效应荟萃分析,并进行单变量与多变量荟萃回归。
- 由两名评价员独立完成数据提取与批判性评价。
主要发现
- 可预防患者伤害的合并患病率为6%(95%CI 5%至7%)。
- 可预防患者伤害中12%(95%CI 9%至15%)为严重或导致死亡。
- 药物相关事件占可预防患者伤害的25%(95%CI 16%至34%)。
- 其他治疗相关事件占可预防患者伤害的24%(95%CI 21%至30%)。
- 与综合医院相比,高级专科(重症监护或手术)的可预防患者伤害更常见(回归系数b=0.07,95%CI 0.04至0.10)。
关键数值与推荐
- 可预防患者伤害合并患病率6%(95%CI 5%至7%)。
- 严重或致死性可预防患者伤害占12%(95%CI 9%至15%)。
- 药物相关可预防伤害占25%(95%CI 16%至34%),其他治疗相关占24%(95%CI 21%至30%)。
- 高级专科较综合医院的可预防伤害回归系数b=0.07(95%CI 0.04至0.10)。
临床怎么用
- 临床应关注可预防患者伤害,尤其药物和其他治疗相关事件。
- 重症监护和手术等高级专科需加强可预防伤害的监测与防范。
- 质量改进应针对性设计循证缓解策略以减少可预防患者伤害。
- 可预防伤害的减少可能带来服务质量和成本效益的提升。
局限性
- 纳入研究均为观察性研究,可能存在异质性和发表偏倚。
- 多数证据来自综合医院,高级专科数据相对有限。
- 原文未报告针对可预防患者伤害的特异性质量改进实践效果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To systematically quantify the prevalence, severity, and nature of preventable patient harm across a range of medical settings globally. DESIGN: Systematic review and meta-analysis. DATA SOURCES: Medline, PubMed, PsycINFO, Cinahl and Embase, WHOLIS, Google Scholar, and SIGLE from January 2000 to January 2019. The reference lists of eligible studies and other relevant systematic reviews were also searched. REVIEW METHODS: Observational studies reporting preventable patient harm in medical care. The core outcomes were the prevalence, severity, and types of preventable patient harm reported as percentages and their 95% confidence intervals. Data extraction and critical appraisal were undertaken by two reviewers working independently. Random effects meta-analysis was employed followed by univariable and multivariable meta regression. Heterogeneity was quantified by using the I2 statistic, and publication bias was evaluated. RESULTS: Of the 7313 records identified, 70 studies involving 337 025 patients were included in the meta-analysis. The pooled prevalence for preventable patient harm was 6% (95% confidence interval 5% to 7%). A pooled proportion of 12% (9% to 15%) of preventable patient harm was severe or led to death. Incidents related to drugs (25%, 95% confidence interval 16% to 34%) and other treatments (24%, 21% to 30%) accounted for the largest proportion of preventable patient harm. Compared with general hospitals (where most evidence originated), preventable patient harm was more prevalent in advanced specialties (intensive care or surgery; regression coefficient b=0.07, 95% confidence interval 0.04 to 0.10). CONCLUSIONS: Around one in 20 patients are exposed to preventable harm in medical care. Although a focus on preventable patient harm has been encouraged by the international patient safety policy agenda, there are limited quality improvement practices specifically targeting incidents of preventable patient harm rather than overall patient harm (preventable and non-preventable). Developing and implementing evidence-based mitigation strategies specifically targeting preventable patient harm could lead to major service quality improvements in medical care which could also be more cost effective.
引用
- Panagioti M, Khan K, Keers RN, et al. Prevalence, severity, and nature of preventable patient harm across medical care settings: systematic review and meta-analysis. BMJ. 2019. PMID: 31315828. doi:10.1136/bmj.l4185
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。